As the smallpox epidemic spreads, Siga Technologies'

Tpoxx oral antiviral smallpox appears to be in high demand

[{"selector":"#anim-8447bc12-a39e-478f-ad3f-3c63a08076dd [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-28.904901080512936%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}]

The company said Thursday it secured an estimated $ 13 million

[{"selector":"#anim-cbd76047-8a17-49ed-bf53-42ccaae82dd6 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(29.91290134789996%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}]

in drug orders, including a $ 11 million

[{"selector":"#anim-cf9abf24-1c76-4d6d-b1c9-db16f3736914 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(0%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

tender from two new countries and a $ 2 million order.

countries in the Asia-Pacific region with a contract for pills.

[{"selector":"#anim-a872363f-14fe-4427-848f-1b71c1e14a4d [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-28.907562897221993%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}]

Phil Gomez, CEO of Siga, said in a statement

[{"selector":"#anim-cf681097-fc85-4cb7-bbcf-ede04d6a7ef6 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-30.68324409928602%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}]

of inquiries about access to Tpoxx.

[{"selector":"#anim-0f2cf236-5ead-4ef5-8e98-7ac76256017e [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(34.152476684023604%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}]